RI
BBNX

RTW Investments’s Beta Bionics BBNX Stock Holding History

RTW Investments’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5M Sell
1,500,000
-500,000
-25% -$5.95M 0.2% 57
2026
Q1 		$20M Sell
2,000,000
-500,000
-20% -$7.4M 0.2% 62
2025
Q4 		$76.2M Sell
2,500,000
-799,191
-24% -$21.3M 0.76% 37
2025
Q3 		$65.6M Hold
3,299,191
– – 0.81% 34
2025
Q2 		$48M Sell
3,299,191
-679
-0% -$9.61K 0.68% 35
2025
Q1 		$40.4M Buy
+3,299,870
New +$61.5M 0.62% 34

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

RTW Investments's BBNX Position: Q2 2026 in Review

RTW Investments reduced its Beta Bionics (BBNX) stake by 25% in Q2 2026, selling an estimated $5.95M and leaving 1,500,000 shares worth $23.5M. The position accounts for 0.2% of the portfolio, ranked #57.

RTW Investments first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $76.2M in Q4 2025. 134 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • RTW Investments held 1,500,000 shares of Beta Bionics worth $23.5M as of Q2 2026.
  • RTW Investments sold 500,000 Beta Bionics shares in Q2 2026, an estimated $5.95M.
  • Beta Bionics made up 0.2% of RTW Investments's portfolio in Q2 2026, its #57 holding.
  • RTW Investments first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • RTW Investments's Beta Bionics position peaked at $76.2M in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.